Cold Chain Challenges Evolving With Industry

November 23, 2016

To ensure the safety and efficacy of inherently fragile regenerative medicines and other temperature-sensitive clinical trial therapeutics and biospecimens, the materials must be maintained within a narrow range of temperatures during shipment and storage. In an interview with, Mark W. Sawicki, Ph.D., chief commercial officer of Cryoport, discusses the growing complexities of cold chain logistics, including the need for advanced equipment and processes and adherence to international shipping regulations. Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Clinical Trials Logistics, Temperature Controlled Logistics, Frozen Biological Shipping

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC